Actinium Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio1719.26263.49115.74
P/B Ratio1.203.834.081.801.73
Price/Tangible Book1.203.834.081.801.73
Price/FCF32.78
Price/OCF31.40
Enterprise Value Ratios
EV/Revenue722.14157.4644.40
EV/FCF19.59
Profitability & Returns
Return on Equity (ROE)-1.11%-0.95%-0.47%-0.37%-0.66%
Return on Assets (ROA)-0.33%-0.33%-0.22%-0.21%-0.36%
Return on Capital Employed (ROCE)-0.61%-0.71%-0.33%-0.34%-0.36%
Leverage & Solvency Ratios
Debt/Equity0.050.060.040.000.01
Debt/FCF0.31
Liquidity Ratios
Current Ratio9.149.2110.4411.6613.62
Quick Ratio8.959.0310.2511.3813.33
Efficiency Ratios
Asset Turnover0.000.010.02
Yield & Distribution Ratios
Earnings Yield-0.97%-0.35%-0.12%-0.19%-0.21%
FCF Yield-0.84%-0.34%0.03%-0.16%-0.21%
Buyback Yield-0.13%-0.10%-0.17%-0.70%-1.44%